Načítá se...

Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions

Engineering of the constant Fc part of monoclonal human IgG1 (hIgG1) Abs is an approach to improve effector functions and clinical efficacy of next-generation IgG1-based therapeutics. A main focus in such development is tailoring of in vivo half-life and transport properties by engineering the pH-de...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunol
Hlavní autoři: Grevys, Algirdas, Bern, Malin, Foss, Stian, Bratlie, Diane Bryant, Moen, Anders, Gunnarsen, Kristin Støen, Aase, Audun, Michaelsen, Terje Einar, Sandlie, Inger, Andersen, Jan Terje
Médium: Artigo
Jazyk:Inglês
Vydáno: AAI 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4432726/
https://ncbi.nlm.nih.gov/pubmed/25904551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1401218
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!